Cover Image
市場調查報告書

心肌缺血:全球臨床實驗檢討

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 242608
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
心肌缺血:全球臨床實驗檢討 Myocardial Ischemia Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月21日 內容資訊: 英文 71 Pages
簡介

冠狀動脈局部或完全阻塞而減少了流入心肌的血液,就會造成心肌缺血。血流量一減少,供給心臟的氧就會減少,心肌缺血就會造成心肌受損,從而造成運血功能低落。冠狀動脈突然阻塞有可能造成心臟病發作。此外,由於心肌缺血,也可能造成嚴重的心律不整。治療方法第一是要改善流入心肌的血流,可使用打開阻塞動脈的藥物療法,或是進行冠狀動脈繞道手術。選擇對心臟健康有利的生活方式,在預防心肌缺血上至為重要。

本報告提供心肌缺血相關的臨床研究最新趨勢分析,提供您疾病·治療方法概要,G7及E7各國的臨床實驗狀況,各地區、Phase、階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 所謂心肌缺血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 心肌缺血佔心臟血管臨床實驗數量的比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 心肌缺血佔心臟血管臨床實驗數量的比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的被實驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 心肌缺血 治療藥

有潛力的藥劑

  • 最新臨床實驗新聞: 心肌缺血

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
    • Gilead Sciences, Inc.
    • Abbott Laboratories
    • Sanofi
    • Merck & Co., Inc.
    • Novartis AG
    • Medicure Inc.
    • Cytori Therapeutics, Inc.
    • Baxter International Inc.
    • Actavis plc
  • 有代表性的研究機關醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • U.S. Department of Veterans Affairs
    • Medical University of Vienna
    • Imperial College London
    • Seoul National University Hospital
    • Hartford Hospital
    • Erasmus MC
    • Ottawa Hospital Research Institute
    • Flinders Medical Centre
    • Assistance Publique - Hopitaux de Paris

5大臨床實驗簡介

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myocardial Ischemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myocardial Ischemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Myocardial Ischemia
    • Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Medicure Inc.
      • Clinical Trial Overview of Medicure Inc.
      • Cytori Therapeutics, Inc.
      • Clinical Trial Overview of Cytori Therapeutics, Inc.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Hartford Hospital
      • Clinical Trial Overview of Hartford Hospital
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Flinders Medical Centre
      • Clinical Trial Overview of Flinders Medical Centre
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flinders Medical Centre, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top